Continuous glucose monitor in acute stroke with diabetes
Part of Brain & nervous system, Heart & circulation, Hormones & metabolism clinical trials.
This study uses a continuous glucose monitor (a small sensor that tracks blood sugar levels) in people who have had a stroke and also have type 2 diabetes. The goal is to see how well the monitor works and if it helps manage blood sugar after a stroke.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You had a recent ischemic stroke (clot-caused) and received a clot-removal procedure called endovascular therapy
- You have type 2 diabetes (either diagnosed, taking diabetes medication, or with high blood sugar or HbA1c at admission)
- You are not pregnant
- You do not have skin infections where the glucose sensor would be placed
- You do not have conditions or take medications that could interfere with the continuous glucose monitor (like low blood pressure, severe kidney disease, or certain drugs)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using a continuous glucose monitor (CGM) helps people who were just diagnosed with type 2 diabetes manage their blood sugar better. Participants wear a small sensor on their arm that checks sugar levels all the time.
This study tests whether using a continuous glucose monitor (CGM) after leaving the hospital helps people with diabetes avoid being readmitted. If you have high blood sugar and need insulin at home, this device might help you manage better.
This trial tests using a continuous glucose monitor to track blood sugar levels in intensive care patients. The monitor sends readings wirelessly, which may help doctors adjust insulin more quickly and safely.
This study looks at how well continuous glucose monitors (small sensors under the skin that track sugar levels) work in ICU patients who need insulin. If you are in the ICU, on insulin, and already have a sensor, you may be able to join.
This study tests a way of checking blood sugar closely after an acute coronary event (a heart-related emergency) in people with type 2 diabetes. It may help doctors understand the best monitoring approach to improve safety and care during recovery.
This study asks people with diabetes to use a continuous glucose monitor (a small device that tracks blood sugar automatically) and share their thoughts about it. Researchers want to understand what features matter most to patients and how well the device works in real life.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.